Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06386029 · ClinicalTrials.gov registry record · NA

The Power Down Pilot Study: A Novel Bedtime Manipulation Protocol

A NA study of Autism and Sleep Disturbance, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT06386029 is a NA study of Autism and Sleep Disturbance that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 10 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06386029, a NA study of Autism and Sleep Disturbance, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The goal of this pilot intervention study is to examine the feasibility and acceptability of a novel bedtime manipulation protocol called "The Power Down" for autistic youth, ages 6-10. The main questions it aims to answer are: 1. Is the Power Down feasible for caregivers to do each night? 2. Do the families find the Power Down an acceptable intervention to address their child's difficulties settling down to fall asleep?

Conditions Studied

Interventions

  • BEHAVIORAL Power Down bedtime manipulation

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2025-07-05
Est. Completion 2026-12
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT06386029

The ClinicalTrials.gov registry entry for NCT06386029 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 183-participant average among 104 other Autism trials with a reported enrollment target (95% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Autism appearing as the primary indexed condition, and to 1 intervention - of which Power Down bedtime manipulation is the first listed.

NCT06386029 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06386029 about?

NCT06386029 is a clinical study titled "The Power Down Pilot Study: A Novel Bedtime Manipulation Protocol". The goal of this pilot intervention study is to examine the feasibility and acceptability of a novel bedtime manipulation protocol called "The Power Down" for autistic youth, ages 6-10. The main questions it aims to answer are: 1. Is the Power Down feasible for caregivers to do each night? 2. Do th...

What is the current status of trial NCT06386029?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-07-05. Estimated completion is 2026-12.

What conditions does trial NCT06386029 study?

This clinical trial studies the following conditions: Autism, Sleep Disturbance.

What interventions are being tested in trial NCT06386029?

The interventions under investigation include: Power Down bedtime manipulation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06386029?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06386029 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.